Warning

Laboratorios ERN, S.A. informs that some of the contents of this website are addressed exclusively to healthcare professionals, authorized for prescribing or dispensing of drugs. Specialized knowledge is required for proper interpretation.

_Resorborina

Resorborina solución bucofaríngea

Sodium benzalkonium, tetracaine hydrochloride, dexametasone and resorcinol.

Anti buccopharyngeal infections.

Thanks to its antiseptic, anaesthetic and anti inflammatory properties, Resorborina is suitable for use in the healing of the majority of inflammatory and infective processes of the buccopharyngeal area, such as: pharyngitis, estomatitis, tongue and mouth sores, and gingivitis among others.


    jar with 200 ml of solution.

    N.C. 694091.4

Gargling: Dilute one teaspoon in two spoonfuls of water.
Spraying: Apply alone or diluted in luke warm water, via an appropriate spray bottle.
In both cases, administer 3 to 6 times a day, according to medical prescription.

Resorborina®
Buccopharyngeal solution    Antiinfective bucco-pharyngeal

PROPERTIES

Inflammatory conditions of the bucco-pharyngeal region require the following therapeutic actions, antiseptic, painkilling, antiphlogistic and astringent. The development of these actions, through its components, characterises RESORBORINA solution as the adequate product to be used in curing the majority of the inflammatory and infective processes so frequent in this anatomic zone.

COMPOSITION per 100ml

Benzalkonium chloride (D.O.E)             100mg
Tetracaine (D.O.E) hydrochloride           20mg
Dexametasone (D.O.E)                                5mg
Resorcinol (D.O.E)                                        2g
Excipients: Alcohol 96º (22.2% v/v), glycerol, simple syrup, soluble essence of peppermint and purified water .c.s

INDICATIONS

Pharyngitis. Stomatitis. Sores in the mouth and tongue. Gingivitis. Pyorrhea. Tonsilitis with different causes. Chronic throat infections. Chronic infections of the lymphoid and throat tissue.

DOSAGE

Gargling: Dilute one teaspoon in two spoonfuls of water.
Spraying: Apply alone or diluted in luke warm water, via an appropriate spray bottle.
In both cases, administer 3 to 6 times a day, according to medical prescription.

WARNING

Contact to your doctor if you have blurred vision or other visual disturbances. We inform sportspeople that this medicine includes a substance which may result in a positive result on a doping test.
‘WARNING ABOUT EXCIPIENTS’: Frequent applications can produce irritation and dry skin.

COUNTERINDICATIONS

Those with a history of hypersensitivity to the components.

SIDE EFFECTS

Rarely, allergic reactions. Adverse effects of unknown frequency: blurred vision
The patient must communicate any side effect not described to their doctor or pharmacist.

INTOXICATION AND ITS TREATMENT

This has not been reported. In case of overdose or accidental ingestion consult the Toxicological Information Service, telephone 915620420.

PRESENTATION

A jar with 100 and 200 ml of solution.

Before its administration ensure that the expiry date on the containers has not passed.

Medicines must not be disposed of in the drains or thrown away. Leave unwanted medicines and containers at the SIGRE point in a chemist. Ask your pharmacist how to dispose of any containers or unneeded medicines. This way you will help look after the environment.

Without prescription.

Medicines must be kept out of sight and reach of children.

Holder of the authorisation for the commercialisation and fabrication of the product.

LABORATORIOS ERN, S.A. Perú, 228 - 08020 Barcelona, España
Tel: 93 314 80 11   Fax: 93 314 40 96

Responsable for fabrication.
Laboratorios ERN, S.A. Gorcs i LLadó, 188 – 08210 Barberá del Vallés, Barcelona. España.

Laboratorios ERN, S.A. Perú, 228 – 08020 Barcelona. España.

Detailed and updated information about this product is available on the webpage of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/